Delineate
ActiveAI-nativeAgents for Accelerated Clinical Trial Design
What it does
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Its site says now · captured 2026-08-23
Delineate — Quantitative evidence for consequential decisions
Delineate creates models from the totality of available evidence — in any therapeutic area — so development, regulatory, and commercial teams act on quantitative evidence in a fraction of the time.
Next to it in Vertical AI agents · AI agents for clinical trial design
- AdamY Combinator W25
AI Powered CAD
- MooresLabAIPlug and Play PnP 2025
Agentic AI for Silicon Engineering
- PhasesY Combinator S25
Automated clinical trial oversight and execution
- OuterportY Combinator S24
EDA for Industrial Control Systems
- AstraeaY Combinator X26
AI Operating System for Clinical Development
- SilimateY Combinator S23
Fast, efficient agents for chip design and debug
- SemioticY Combinator F25
Studio-Grade Design at Scale
- Agentin AIY Combinator W25
AI Agents that automate enterprise software processes